Mednax (MD) Tops Q3 EPS by 1c; Guides Q3 EPS Below
Tweet
Share
E-mailGet Alerts MD Hot Sheet
Join SI Premium – FREE
Mednax (NYSE: MD) reported Q3 EPS of $1.19, $0.01 better than the analyst estimate of $1.18. Revenue for the quarter came in at $407.7 million versus the consensus estimate of $400.27 million.
Mednax sees Q4 2011 EPS of $1.15-$1.20, versus the consensus of $1.21.
Mednax sees Q4 2011 EPS of $1.15-$1.20, versus the consensus of $1.21.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
